Keynote Speakers

Professor Brian Kelly, BMed (Newcastle), PhD, FRANZCP, FAChPM

Professor Brian Kelly is Head of the School of Medicine and Public Health and Professor of Psychiatry at the University of Newcastle, Australia, and Adjunct Professor, Department of Oncology, Cummings School of Medicine, University of Calgary. He has undertaken studies across mental health, palliative and end-of-life care, and psycho-oncology including research to explore ways to improve identification of psychosocial needs, health service models in psycho-oncology and integration of psychosocial care into cancer services. This includes strategies to improve education and support of health professionals in oncology and palliative care, including methods of clinical supervision and support, education in communication skills, and addressing the impact of care on clinicians. His experience also extends to addressing health care needs and services in rural and remote regions, and the psychosocial needs of Indigenous people with cancer.

Professor Phyllis Butow, BA(Hons), MPH, MClinPsych, PhD

Phyllis Butow is Professor, and NHMRC Senior Principal Research Fellow in the School of Psychology at the University of Sydney. She founded the Australian Psycho-Oncology Co-operative Research Group (PoCoG) and the Centre for Medical Psychology and Evidence-based Decision-making (CeMPED). Prof Butow has won many awards, including the IPOS Bernard Fox award for outstanding contribution to Psycho-Oncology research in 2009 and an Order of Australia (AM) in 2014. She has conducted a large body of research on doctor-patient communication, patient involvement in decision-making, patient and family support, cancer genetics, and outcomes and needs of immigrants with cancer. Recently she has had a major interest in fear of cancer recurrence (FCR), leading the ConquerFear trial, a multi-centre randomised controlled trial of a meta-cognitive, face-to-face psychologist-delivered intervention, which showed high efficacy immediately post therapy and at 6 months follow-up, and has sparked high international interest and related collaborative studies.

Professor Toshi A. Furukawa, MD, PhD

Professor Toshi A. Furukawa is currently Professor of the Departments of Health Promotion and Human Behavior, and of Clinical Epidemiology at Kyoto University Graduate School of Medicine / School of Public Health. Prof Furukawa’s major areas of interest and expertise include clinical epidemiology, evidence synthesis, and clinical psycho-pharmacology and cognitive-behavior therapy in mood and anxiety disorders. He is author and co-author of over 450 peer-reviewed articles. His bio was featured in the Lancet Psychiatry in May 2020 (

Dr. Paul Jacobsen, PhD

Paul Jacobsen received his doctoral degree in Psychology from Michigan State University and completed post-doctoral training in Psychosocial Oncology at Memorial Sloan Kettering Cancer Center. He is currently an Associate Director in the U.S. National Cancer Institute’s Division of Cancer Control and Population Sciences where he directs the Healthcare Delivery Research Program. In this position, he leads a team whose mission is to advance innovative research to improve the delivery of cancer-related care to patients, families, and communities. Before entering government service, Dr. Jacobsen served as Associate Center Director for Population Science at the Moffitt Cancer Center and Professor of Psychology at the University of South Florida. Over the past 30 years, his research has focused on using knowledge from the behavioral and social sciences to understand and address quality of life and quality of care issues in oncology. Dr. Jacobsen is a past recipient of the Jimmie Holland Distinguished Leadership Award from the American Psychosocial Oncology Society (APOS), and the Bernard Fox Memorial Award from the International Psycho-Oncology Society (IPOS). He is also a past president of APOS and has served in several capacities on the board of IPOS.

Dr. Wendy WT Lam, RN, PhD, FFPH

Dr. Wendy WT Lam is currently Associate Professor at the School of Public Health, The University of Hong Kong. She is the director of the HKU Jockey Club Institute of Cancer Care (JCICC). She is also the head of the Division of Behavioural Sciences, at the School of Public Health. She is an active contributor in International Psycho-oncology Society, being a board of director. She was an elected IPOS Board of Director from 2014-2018. She is currently the treasurer, IPOS Executive Board from 2019-2021, and chairs or participates in various committees. She was awarded the 2007 Hiroomi Kawano Young Investigator Award by the International Psycho-Oncology Society for her work on Chinese women with breast cancer. Her research interests focus on psychosocial adaptation patterns and service optimization in cancer patients. She has produced over 200 outputs, comprising 110 publications She is appointed as an Associate Editor for Psycho-oncology and for Patient Education and Counseling. She is currently leading the JCICC team to develop a care model to integrate psychosocial services into routine cancer care. Under her directorship, JCICC has recently established the first cancer survivorship clinic in Hong Kong offering support in managing post-treatment symptoms, as well as personalized diet and physical activity advice.

Dr. Ronald Epstein

Ronald Epstein MD -- family physician, educator, researcher and writer -- has devoted his career to improving patient-physician communication and clinician mindfulness though groundbreaking research and innovative educational programs. He co-directs the Center for Communication and Disparities Research and Mindful Practice Programs at the University of Rochester, where he is Professor of Family Medicine, Oncology and Medicine (Palliative Care). A graduate of Harvard Medical School, he has received numerous humanism awards and the American Cancer Society’s highest award, the Clinical Research Professorship. The author of over 300 publications, his first book, Attending: Medicine, Mindfulness and Humanity, was released in 2017.

Dr. Zeev Rosberger, PhD

Dr. Zeev Rosberger is Senior Investigator, Lady Davis Institute for Medical Research, Jewish General Hospital and Associate Professor, Departments of Oncology, Psychiatry and Psychology, McGill University in Montreal Quebec, Canada. He has over 40 years of experience and expertise in psychosocial oncology. He has led multiple studies to understand the impact of cancer and treatments on the patient experience and evaluating interventions designed to reduce symptoms of distress and enhance quality of life. His current research focus is on the prevention of HPV related cancers by studying psychosocial correlates influencing Pap and HPV DNA testing and uptake of the HPV vaccine.

Professor Sharon Hanley, PhD

SHARON HANLEY is a cancer epidemiologist and Assistant Professor in the Department of Obstetrics and Gynecology at Hokkaido University. She obtained her PhD. from the Departments of Public Health and Reproductive Endocrinology and Oncology at the same university. Sharon’s research interests include vaccine hesitancy, correlates of HPV vaccine acceptance in parents of Japanese girls and using HPV self-sampling to encourage non-attenders to undergo cervical screening. She currently holds grants from the Great Britain Sasakawa Foundation and the Anglo-Japan Daiwa Foundation to carry out collaborative research with the universities of Edinburgh and Aberdeen focusing on 21st century technology to improve access to and participation in cervical cancer control programmes.

Ms. Teresa Norris

Teresa Norris is the Founder and President of HPV Global Action / VPH Action Globale and has developed synergies at different organizational and governmental levels evolving from local initiatives and up to the international stage. Teresa and her team work with healthcare professionals, clinicians, and health systems around the world. Teresa is a passionate Sexual and Reproductive Health Specialist and expert on HPV issues with over 16 years of experience, using evidence-based communication methods, championing disease prevention strategies, and offering forward-thinking programs that inform people how to have healthy relationships.

Dr. Shannon Wiltsey-Stirman, PhD

Shannon Wiltsey Stirman is an Associate Professor at Stanford University’s Department of Psychiatry and Behavioral Sciences. Her research focuses on implementation and sustainability of evidence-based psychosocial treatments in public mental health settings. Recent work has included studies comparing strategies to train therapists to provide evidence-based therapies, research on adaptation, and studies on strategies to sustain effective treatments in large healthcare systems. She and her collaborators have developed the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) and the Integrated Sustainability Framework. Dr. Stirman was a Fellow and later an Expert Faculty Member of the Implementation Research Institute, and later served as faculty for the United States National Cancer Institute’s Training Institute for Dissemination and Implementation Research in Cancer. Currently, she serves on the Board of Directors of the American Psychological Association and the Society of Implementation Research Collaboration (SIRC). She was awarded the Association for Behavior and Cognitive Therapies Mid-Career Innovator Award in 2018. Her research has been funded by the National Institute of Mental Health, the Canadian Institute for Health Research, and the VA QUERI program.


Professor Anja Mehnert-Theuerkauf, PhD

Anja Mehnert-Theuerkauf, PhD, is Professor and Chair of the Department of Medical Psychology and Medical Sociology at the University Medical Center, University of Leipzig, Germany. In 2005, she completed her PhD on PTSD in breast cancer at the University of Hamburg and worked at the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center, NYC, as a postdoctoral fellow (2007-2008). In 2010, she completed her Habilitation thesis at the University Hamburg as well as her training as a licenced psychological psychotherapist in 2013. She holds editorial positions for journals such as Psycho-Oncology, Journal of Cancer Survivorship and Frontiers Psycho-Oncology. Her academic interests include mental distress, cancer survivorship and psychotherapy research.

Professor Christoffer Johansen, M.D., Ph.D. & Dr. Med. Sci.

Professor Christoffer Johansen is a full professor in Cancer Late Effects, Rigshospitalet, University of Copenhagen, Denmark. He initiated, established and headed the first department of psychosocial oncology applying epidemiological methods at the Danish Cancer Society Research Centre. The research aimed at evaluating how the mind may cause cancer, the effect of a cancer disease on psychosocial outcomes and interventions to improve psychosocial outcomes in cancer survivors. The main focus has been on depression in cancer and close to 20 randomized clinical intervention trials has been conducted under his supervision. He has supervised close to 60 Ph.D. students and besides more than 600 peer reviewed publications, published books on religious belief and health, personality and disease, living with cancer, and cancer late effects. Professor Johansen has been teaching since he was a medical student (1978 to 1986) mainly in anatomy, physiology and social medicine for pre-graduate students and later in epidemiology and academic writing in post-graduate education. He has been the President of IPOS from 2003 to 2006. He loves skiing, walking in mountains (no places in Denmark) and gardening.

Dr. Sylvie Lambert, RN, PhD

Dr. Sylvie Lambert is Associate Professor at the Ingram School of Nursing, McGill University as well as Scientist at the St. Mary’s Research Centre, Montreal. Dr. Lambert is also the recipient of a CIHR Canada Research Chair (Tier 2) in self-care and illness self-management support interventions. In this position, the objectives of her research programs includes: 1) developing and evaluating low-cost self-care and illness self-management interventions that are sustainable to enhance translation in practice, 2) implementing real-world patient-reported outcome (PRO) and caregiver-reported outcome (CRO) screening programs, 3) adapting evidence-based self-management interventions to the needs of patients from a culturally and linguistically diverse background and their caregivers, and 4) using advanced psychometric approaches for improving the precision and efficiency of outcome evaluations. She has received national and international recognition of her work in the form of several awards and prizes, including International Psycho-Oncology Society (IPOS) Hiroomi Kawano New Investigator Award in 2014.

Dr. Maiko Fujimori

Dr. Maiko Fujimori is currently a section chief of Psychological Science, Division of Health Care Research, Center for Public Health Sciences, National Cancer Center in Japan. Her specialty is clinical psychology, psycho-oncology and behavioral science. She has been studied in promoting communication among patients, family members and medical staffs in oncology setting, supporting decision making for cancer patients, mental health care delivery to cancer patients, and suicide prevention for cancer patients. She conducts clinical studies, observational studies, qualitative studies, as well as develops clinical guidelines related to psycho-oncology.

Professor. Andrea Cheville, M.D. and M.S.C.E.

Dr. Andrea Cheville is a Professor of Physical Medicine and Rehabilitation and is the Physical Medicine and Rehabilitation Department Chair at Mayo Clinic in Rochester, MN. She received her MD degree from Harvard Medical School in 1993 and her Master of Science in Clinical Epidemiology degree from the University of Pennsylvania in 2006. Her areas of clinical and research interest are lymphedema and cancer rehabilitation, palliative medicine, and patient-reported outcomes. She is board-certified in Physical Medicine and Rehabilitation, Pain Medicine, and Palliative Care. She has received funding from the National Institutes of Health, National Cancer Institute, and the U.S. Department of Defense. She was elected to the National Institute of Medicine in October 2016.

Copyright © IPOS2021. All Rights Reserved.